How to better stratify the risk of differentiated thyroid carcinomas: the key role of radioactive iodine therapy, age, and gender

被引：0

作者：

Arnoldo Piccardo

Giacomo Siri

Stefano Raffa

Marco Castellana

Luca Foppiani

Gianluca Bottoni

Martina Ugolini

Angelina Cistaro

Ugo Catrambone

Vania Altrinetti

Michela Massollo

Anselmo Arlandini

Luca Giovanella

Manlio Cabria

Pierpaolo Trimboli

机构：

[1] E.O. “Ospedali Galliera”,Department of Nuclear Medicine

[2] University of Genoa,Department of Mathematics

[3] Galliera Hospital,Scientific Directorate

[4] IRCCS Ospedale Policlinico San Martino,Nuclear Medicine Unit

[5] National Institute of Gastroenterology “Saverio De Bellis”,Department of Internal Medicine

[6] E.O. “Ospedali Galliera”,Department of Surgery

[7] Galliera Hospital,Clinic for Nuclear Medicine and Competence Center for Thyroid Diseases, Imaging Institute of Southern Switzerland

[8] Ente Ospedaliero Cantonale,Clinic for Nuclear Medicine

[9] University Hospital and University of Zurich,Faculty of Biomedical Sciences

[10] Università della Svizzera Italiana (USI),undefined

来源：

European Journal of Nuclear Medicine and Molecular Imaging | 2021年 / 48卷

关键词：

DTC; Risk stratification; RAI; Elderly; Gender;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：822 / 830

页数：8

共 50 条

[21] Clinicopathological features of differentiated thyroid carcinoma as predictors of the effects of radioactive iodine therapy
Liu, Wen
Jiang, Beibei
Xue, Jingli
Liu, Ruijing
Wei, Yuqing
Li, Peifeng
ANNALS OF DIAGNOSTIC PATHOLOGY, 2024, 69
[22] Severe Hyponatremia Following Radioactive Iodine Therapy in Patients with Differentiated Thyroid Cancer
Kim, Seung Kyu
Yun, Gi Young
Kim, Ki Hyun
Park, Seung Kyo
Choi, Hoon Young
Ha, Sung Kyu
Park, Hyeong Cheon
THYROID, 2014, 24 (04) : 773 - 777
[23] Factors Associated with Dose Determination of Radioactive Iodine Therapy for Differentiated Thyroid Cancer
Hong C.M.
Ahn B.-C.
Nuclear Medicine and Molecular Imaging, 2018, 52 (4) : 247 - 253
[24] Influence of radioactive iodine therapy on liver function in patients with differentiated thyroid cancer
Wang, Sen
Liang, Chao
Zhao, Li
Meng, Zhaowei
Zhang, Chunmei
Jia, Qiang
Tan, Jian
Yang, Hui
Liu, Xiangxiang
Wang, Xiaoran
NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (12) : 1113 - 1120
[25] The efficacy of adjuvant radioactive iodine therapy for patients with recurrent differentiated thyroid carcinoma
Maskell, David
Benson, Richard
Harrison, Inge
Barnett, Gill
Jefferies, Sarah
CLINICAL ONCOLOGY, 2018, 30 : E2 - E3
[26] Predictive Factors of Radioactive Iodine Therapy Refractoriness in Patients with Differentiated Thyroid Carcinoma
Lakhdar, Majdouline Bel
Mouaden, Ayat
Zekri, Mourad
Alami, Dounia
Zarouf, Hamza
Ghfir, Imad
Guerrouj, Hasnae
WORLD JOURNAL OF NUCLEAR MEDICINE, 2024, 23 (03) : 185 - 190
[27] Clinicopathological features and outcomes after radioactive iodine treatment of oncocytic well-differentiated thyroid carcinomas
Amouri, Wissem
Charfeddine, Salma
Charfi, Slim
Jardak, Issam
Boudawara, Tahia
Guermazi, Fadhel
NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (09) : 888 - 893
[28] Early Sialadenitis After Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Prevalence and Predictors
Riachy, Ruba
Ghazal, Nisrine
Haidar, Mohamad B.
Elamine, Ahmad
Nasrallah, Mona P.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2020, 2020
[29] Insights into the association between radioactive iodine therapy and cardiovascular disease in differentiated thyroid cancer
Stanciu, A. E.
Bolovan, M.
Stanciu, M. M.
Zamfirescu, A.
CLINICA CHIMICA ACTA, 2024, 558
[30] Surgical approach and radioactive iodine therapy for small well-differentiated thyroid cancer
Momesso, D. P.
Vaisman, F.
Caminha, L. S. C.
Pessoa, C. H. C. N.
Corbo, R.
Vaisman, M.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2014, 37 (01) : 57 - 64

← 1 2 3 4 5 →